|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940 |
|
| |||||||||||||||||||||||||||||||||||||||||||||||||
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | |||
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. | SEC 1474 (9-02) |
1. Title of Derivative Security (Instr. 3) |
2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date (Month/Day/Year) | 3A. Deemed Execution Date, if any (Month/Day/Year) | 4. Transaction Code (Instr. 8) |
5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) |
6. Date Exercisable and Expiration Date (Month/Day/Year) |
7. Title and Amount of Underlying Securities (Instr. 3 and 4) |
8. Price of Derivative Security (Instr. 5) |
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) |
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) |
11. Nature of Indirect Beneficial Ownership (Instr. 4) |
||||
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
Employee Stock Option (Right to Buy) | $ 15.08 | 01/24/2014 | D | 90,000 | 04/30/2008(2) | 04/30/2017 | Common Stock | 90,000 | (3) | 0 | D | ||||
Employee Stock Option (Right to Buy) | $ 13.97 | 01/24/2014 | D | 14,000 | 06/15/2008(2) | 06/15/2017 | Common Stock | 14,000 | (3) | 0 | D | ||||
Employee Stock Option (Right to Buy) | $ 9.96 | 01/24/2014 | D | 8,295 | 01/11/2009(2) | 01/11/2018 | Common Stock | 8,295 | (3) | 0 | D | ||||
Employee Stock Option (Right to Buy) | $ 9.99 | 01/24/2014 | D | 9,975 | 06/13/2009(2) | 06/13/2018 | Common Stock | 9,975 | (3) | 0 | D | ||||
Employee Stock Option (Right to Buy) | $ 13.5 | 01/24/2014 | D | 52,593 | 01/08/2010(2) | 01/08/2019 | Common Stock | 52,593 | (3) | 0 | D | ||||
Employee Stock Option (Right to Buy) | $ 8.86 | 01/24/2014 | D | 13,714 | 01/07/2011(2) | 01/07/2020 | Common Stock | 13,714 | (3) | 0 | D | ||||
Employee Stock Option (Right to Buy) | $ 11.31 | 01/24/2014 | D | 50,000 | 06/07/2011(2) | 06/07/2020 | Common Stock | 50,000 | (3) | 0 | D | ||||
Employee Stock Option (Right to Buy) | $ 17.84 | 01/24/2014 | D | 40,261 | 01/05/2012(2) | 01/05/2021 | Common Stock | 40,261 | (3) | 0 | D | ||||
Employee Stock Option (Right to Buy) | $ 17.98 | 01/24/2014 | D | 40,261 | 06/06/2012(2) | 06/06/2021 | Common Stock | 40,261 | (3) | 0 | D | ||||
Employee Stock Option (Right to Buy) | $ 28.16 | 01/24/2014 | D | 27,265 | 01/05/2013(2) | 01/05/2022 | Common Stock | 27,265 | (3) | 0 | D | ||||
Employee Stock Option (Right to Buy) | $ 23.37 | 01/24/2014 | D | 34,570 | 01/03/2014(2) | 01/03/2023 | Common Stock | 34,570 | (3) | 0 | D | ||||
Employee Stock Option (Right to Buy) | $ 27.79 | 01/24/2014 | D | 32,516 | 06/10/2014(2) | 06/10/2023 | Common Stock | 32,516 | (3) | 0 | D | ||||
Employee Stock Option (Right to Buy) | $ 20.07 | 01/24/2014 | D | 35,723 | 06/04/2013(2) | 06/04/2022 | Common Stock | 35,723 | (3) | 0 | D |
Reporting Owner Name / Address | Relationships | |||
Director | 10% Owner | Officer | Other | |
Pietrusko Robert 730 STOCKTON DRIVE EXTON, PA 19341 |
VP, Regulatory & Quality |
/s/ J. Peter Wolf, attorney-in-fact | 01/28/2014 | |
**Signature of Reporting Person | Date |
* | If the form is filed by more than one reporting person, see Instruction 4(b)(v). |
** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
(1) | Performance-based awards entitling the reporting person to shares of VPHM common stock upon the satisfaction of certain criteria were deemed satisfied in connection with the merger of ViroPharma Incorporated with and into Shire Pharmaceutical Holdings Ireland Limited, effective as of January 24, 2014 and canceled in exchange for an amount equal to $50 per share. |
(2) | The options vest in four equal annual installments beginning on the anniversary date from time of grant. |
(3) | This derivative security, regardless of whether otherwise previously vested, was canceled in connection with the merger of ViroPharma Incorporated with and into Shire Pharmaceutical Holdings Ireland Limited, effective as of January 24, 2014 in exchange for a cash payment representing the difference between the per-share exercise price of the stock option and $50. |